Chemed Corp. Hits New 52-Week High at USD 516.53

Chemed Corp. has reached a significant milestone by hitting a new 52-week high of USD 516.53 on July 20, 2026. This achievement highlights the stock's notable activity within the hospital industry, where Chemed operates as a small-cap company with a market capitalization of approximately USD 12.84 billion. Despite a one-year performance decline of 5.72%, Chemed Corp. has shown resilience in its financial metrics. The company boasts a price-to-earnings (P/E) ratio of 48.00, indicating a premium valuation compared to its peers. Additionally, Chemed's return on equity stands at an impressive 27.10%, reflecting strong profitability relative to shareholder equity. The stock's dividend yield is currently at 0.27%, providing a modest return to shareholders. With a price-to-book ratio of 13.11, Chemed Corp. continues to maintain a robust market position. The recent high underscores the stock's performance trajectory, contrasting with its 52-week low of USD 365.51, and marks a noteworthy point in the company's ongoing financial narrative.